RA Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328M Hold
10,428,437
3.48% 6
2025
Q4
$259M Hold
10,428,437
2.65% 11
2025
Q3
$169M Buy
10,428,437
+525,804
+5% +$7.46M 2.08% 14
2025
Q2
$130M Buy
9,902,633
+993,542
+11% +$14.3M 2.19% 12
2025
Q1
$196M Hold
8,909,091
3.27% 7
2024
Q4
$238M Hold
8,909,091
3.17% 6
2024
Q3
$238M Hold
8,909,091
2.74% 9
2024
Q2
$160M Hold
8,909,091
2.12% 15
2024
Q1
$163M Buy
+8,909,091
New +$142M 2.07% 11
2022
Q2
Sell
-2,613,623
Closed -$25.4M 92
2022
Q1
$25.4M Hold
2,613,623
0.55% 51
2021
Q4
$39.9M Hold
2,613,623
0.7% 42
2021
Q3
$43.4M Hold
2,613,623
0.6% 43
2021
Q2
$55.7M Hold
2,613,623
0.89% 35
2021
Q1
$84.9M Buy
+2,613,623
New +$84.8M 1.28% 22

Other funds holding EWTX